Skip to content
★ Sign in to follow
RW

Robert Wong

Directeur comptable
Total declarations
22
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€884k

Latest filing published 05 Dec 2024 for CYTOKINETICS INC.

Filing timeline

BuySale
Robert Wong

Insider track record

Disclosed buys
0
Disclosed sells
4

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Robert Wong: trading record in brief

Robert Wong (senior executive) discloses dealings in Cytokinetics Inc to SEC (Form 4). In total, 22 filings cover trades dated from 6 March 2020 to 3 December 2024.

Sales make up the whole of the open-market record (4 sales, €884k). The rest of the record consists of 18 share grants. In 2024 alone, the filings show no purchases and 1 sale.

The latest filing, published on 5 December 2024, reports a share grant in Cytokinetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert Wong

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    0SEC
    764 shares0Common StockSEC:0001127602-24-028723:0
  • ▼
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    635,978 USD56SEC
    13,011 shares@ US$48.8847.4% of flowCommon StockSEC:0001127602-24-017303:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    0SEC
    4,079 shares0Common StockSEC:0001127602-24-010518:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    120,673 USD34SEC
    1,783 shares@ US$67.689.0% of flowCommon StockSEC:0001127602-24-009017:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    27,078 USD33SEC
    692 shares@ US$39.132.1% of flowCommon StockSEC:0001127602-23-009274:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    0SEC
    6,000 shares0Common StockSEC:0001127602-23-009290:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    98,366 USD34SEC
    2,484 shares@ US$39.607.5% of flowCommon StockSEC:0001127602-23-008873:0
  • ▼
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    100,999 USD46SEC
    2,234 shares@ US$45.217.7% of flowCommon StockSEC:0001127602-23-006291:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    22,506 USD33SEC
    510 shares@ US$44.131.7% of flowCommon StockSEC:0001127602-23-005922:0
  • ▼
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    135,180 USD46SEC
    3,004 shares@ US$45.0010.1% of flowCommon StockSEC:0001127602-23-003549:0
  • ▼
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    85,428 USD46SEC
    2,100 shares@ US$40.686.7% of flowCommon StockSEC:0001127602-22-025622:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    50,973 USD19SEC
    1,384 shares@ US$36.833.8% of flowCommon StockSEC:0001061983-22-000071:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    54,451 USD19SEC
    1,447 shares@ US$37.634.0% of flowCommon StockSEC:0001061983-22-000057:0
  • ◆
    VP, Chief Accounting OfficerExecutivesCytokinetics Inc
    0SEC
    737 shares0Common StockSEC:0001061983-22-000029:0

14 of 14 declarations